- Report
- June 2022
- 98 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- June 2022
- 97 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- June 2022
- 98 Pages
Middle East, Africa
From €1432EUR$1,500USD£1,199GBP
- Report
- June 2022
- 102 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
- 124 Pages
Global
From €3500EUR$3,929USD£3,035GBP
-
Journal - March 2025
- 66 Pages
Global
From €406EUR$425USD£340GBP
- Report
- July 2022
- 176 Pages
Global
From €3298EUR$3,456USD£2,764GBP
Interventional Oncology is a field of medicine that uses minimally invasive techniques to diagnose and treat cancer. It is a subspecialty of radiology and involves the use of medical imaging to guide the delivery of treatments such as ablation, embolization, and biopsy. These treatments are used to reduce tumor size, improve symptoms, and provide a more accurate diagnosis. Interventional Oncology also offers the potential for targeted therapies, such as drug-eluting beads, to be delivered directly to the tumor.
Interventional Oncology is a rapidly growing field, with new technologies and treatments being developed to improve patient outcomes. It is becoming increasingly important in the diagnosis and treatment of cancer, as it offers a less invasive alternative to traditional surgery.
Companies in the Interventional Oncology market include AngioDynamics, BTG, Boston Scientific, Cook Medical, Merit Medical, and Terumo. Show Less Read more